Mural Health has announced a strategic partnership with Clinflash. The partnership will expand the capacity and global market of patient payments for clinical trials. Having reached a global agreement, the partnership intends to enable sponsors to access patient payment solutions in the Chinese market and beyond.
Mural Health's participant management platform Mural Link™, has introduced a patient payments system and Clinflash ePAY (Clinical Trial Electronic Payment Solution) uses digital service technology to improve payment efficiency and security. The company has established close cooperation with key hospitals in China to provide third-party mobile payment solutions for Chinese trial participants.
Mural Health and China-based Clinflash Partner to Expand Global Patient Payment Solutions. (2023 May, 23). Cision PR Newswire.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Novel Agent Shows Superiority Over Placebo in Reducing Monthly Migraine Days
September 5th 2024Lu AG09222 shows promise as first-in-class medication that prevents neurogenic inflammation, vasodilation, and parasympathetic lacrimation, which are considered to be surrogate markers of migraine attacks.